One of the longtime members of The Beach Boys, Jeffrey Foskett, died this week at age 67, it was confirmed by Beach Boys co-founder Brian Wilson. He had been battling anaplastic thyroid cancer for years.
He added: “He was a great musical leader and guitarist and he could sing like an angel. I first met Jeff in 1976 when he knocked on my door in Bel Air and I invited him in, and we were friends ever since. I don’t know what else to say. Love and Mercy to Jeff’s family and friends, we will remember him forever.”
Born in 1956 in San Jose, California, Mr. Foskett recalled meeting Mr. Wilson in 1976 when he visited the musician’s home in Bel-Air
Several years later, he joined Beach Boys after member Mike Love saw him performing in Santa Barbara. He performed alongside fellow members Mr. Love, Dennis Wilson, Al Jardine, and Bruce Johnson as well as Brian Wilson at times throughout the 1980s.
Ultimately, he was dismissed from the group and pursued a solo career throughout the 1990s, while also performing as part of the Brian Wilson Band. Notably, he appeared on a number of Wilson solo albums, including the critically acclaimed “Brian Wilson Presents Smile,” released in 2004, among others.
Mr. Foskett joined the Beach Boys for their 50th reunion tour in 2012, performing on the album, “That’s Why God Made the Radio.” He remained with the Beach Boys until 2019 when he departed the band due to health issues.
“Because I had remained on good terms with everyone, when it was proposed that this reunion celebration would happen, there was absolutely no problem, no issue at all,” he said. “I’ve had some great talks with everybody, and it’s just a really, really fun and fulfilling time.”
“Jeff had a contagious positive spirit and never gave up hope. God bless his beautiful spirit and zest for life, we will really miss him and cherish all the great times we shared together. Keeping his wife Diana, his daughter and family and fans everywhere in our thoughts. Rest in peace Jeff and thanks for always making us smile,” he continued to say.
“Tragically, the five year survival from this type of cancer is less than 5 percent, with most patients dying within just a few months of the diagnosis. However, with new advances in treatment, there has been progress in helping patients with this disease,” the university website adds.